News

British Columbia is improving the sustainability of its PharmaCare program by expanding the use of biosimilars, which will create opportunities for new drug listings and boost existing coverage for patients. The Arthritis Society is gratified that our patient-focused recommendations to the...

British Columbians on certain drugs for arthritis and diabetes will have six months to transition to equivalent less-costly drugs, as the province expands use of “biosimilars.” The move is expected to save $96 million over the first three years.

Spectrum Cannabis, the medical division of Canopy Growth Corporation, is pleased to announce a partnership with the Arthritis Society to raise awareness and educate people about living with arthritis, including the potential of medical cannabis as a treatment for arthritis symptoms and the...

The Arthritis Society acknowledges the release of today's interim report from the Advisory Council for the Implementation of National Pharmacare and urges the government to adopt a model that expands patient access to medicines while ensuring choice to medically necessary pharmaceuticals is...

An algorithm predicted disease outcome in children suffering from arthritis, helping doctors better tailor treatment.

Matching donation supports life-changing research into arthritis affecting 24,000 young CanadiansVANCOUVER, February 1, 2019 – The Arthritis Society is pleased to announce a partnership with Cassie & Friends (C&F) to support our research investments into juvenile idiopathic...

A new study by Canadian researchers has found that men and women remember pain differently and that the memory of earlier pain makes men hypersensitive to later pain, but not women.

New research at the University of Toronto will examine arthritis pain caused by inflammation.

Halifax children's hospital works with volunteers at non-profit organization to help parents adapt.